Discover 700 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma offers many options for individuals interested in paid research studies as both healthy participants and those with specific health conditions. Leading research centers in Oklahoma City, Tulsa, and Norman are recruiting volunteers, giving access to the latest treatments and specialized care.
Filter
1
Filter results
Results: 700
Circulating Tumor DNA Response In Urothelial Cancer
for
Urothelial Carcinoma
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18+
Code: NCT07183319
Phase2, Recruiting
Meloxicam in Mohs Micrographic Surgery
for
Postoperative Pain, Acute, Skin Cancer
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18 - 70+
Code: NCT07200544
Recruiting
iAmHealthy Clinical Practice Guideline (CPG)
for
Pediatric Obesity, Rural Health, Clinical Practice Guideline
Location: Charleston SC, Kansas City KS, Omaha NE,
Sponsor: University of Kansas Medical Center
Sex: All
Age: 6 - 11
Code: NCT06888011
Recruiting
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
Location: Boston MA, Stony Brook NY, Manhasset NY, New York NY,
Sponsor: phenox Inc.
Sex: All
Age: 18+
Code: NCT07143019
Recruiting
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
for
Left Ventricle Remodeling, Left Ventricle Dilated, CHF
Location: Hershey PA, Miami FL, Chicago IL, Kansas City MO,
Sponsor: BioVentrix
Sex: All
Age: 18+
Code: NCT06813820
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
for
Chronic Spontaneous Urticaria
Location: Quebec, White Marsh MD, Ottawa, Niagara Falls,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07219615
Phase2, Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
for
Intracerebral Hemorrhage
Location: Boston MA, Worcester MA, Stony Brook NY, Manhasset NY,
Sponsor: Joseph Broderick, MD
Sex: All
Age: 18 - 70+
Code: NCT07227246
Phase3, Recruiting
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
for
Heart, Heart Failure With Preserved Ejection Fraction (HFPEF)
Location: Brick NJ, Durham NC, North Miami Beach FL,
Sponsor: Vasa Therapeutics
Sex: All
Age: 50+
Code: NCT07219511
Phase1, Recruiting
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
for
Hypertension, Uncontrolled Hypertension
Location: Norfolk VA, Kinston NC, Burke VA, Charleston SC,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07090161
Phase2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
for
Cervical Cancer
Location: Halifax, Providence RI, Quebec, Sherbrooke, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07216703
Phase3, Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Location: Boston MA, New Haven CT, Hackensack NJ, Philadelphia PA,
Sponsor: Normunity AccelCo, Inc.
Sex: All
Age: 18+
Code: NCT07182149
Phase1, Recruiting
I-DECIDE After Bronchiolitis Hospitalization
for
Bronchiolitis Acute
Location: Bangor ME, Boston MA, Providence RI, Manchester NH,
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 2
Code: NCT07243652
Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, West Chester PA, Kingston, Miami FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT07177339
Phase3, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT06900595
Phase2, Recruiting
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
for
Breast Cancer, Prostate Cancer
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18+
Code: NCT07014618
Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Providence RI, Norwich CT, Hartford CT, New Haven CT,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase3, Recruiting
Clinical Pre-screening Protocol for Ovarian Cancer
for
Ovarian Cancer
Location: New York NY, Tampa FL, Atlanta GA, Oklahoma City OK,